|
Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol. 2008 Feb 26;51(8):818-25. doi: 10.1016/j.jacc.2007.11.035. PubMed PMID: 18294566.
AÑO: 2008; IF: 11.438
|
18294566
|
García-Almagro FJ, Gimeno JR, Villegas M, Hurtado J, Teruel F, Cerdán MC, González-Carrillo J, Pascual D, Rodríguez-Barranco M, Valdés M. Prognostic value of the Thrombolysis in Myocardial Infarction risk score in a unselected population with chest pain. Construction of a new predictive model. Am J Emerg Med. 2008 May;26(4):439-45. doi: 10.1016/j.ajem.2007.07.011. PubMed PMID: 18410812.
AÑO: 2008; IF: 1.188
|
|
Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27. PubMed PMID: 18514934.
AÑO: 2008; IF: 3.691
|
|
Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035. PubMed PMID: 18585501.
AÑO: 2008; IF: 4.285
|
|
Romero-Puche A, Marín F, González-Carrillo J, García-Honrubia A, Climent V, Feliu E, Ruiz-Espejo F, Payá E, Gimeno-Blanes JR, de la Morena G, Valdés-Chavarri M. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy. Rev Esp Cardiol. 2008 Aug;61(8):853-60. English, Spanish. PubMed PMID: 18684368.
AÑO: 2008; IF: 2.88
|